File Type: Product Documents
In this resource, we look at how the ACIST CVi® Contrast Delivery System optimizes contrast supply. Managing contrast supply can help decrease both dose and waste of contrast, while also reducing the risk of post-procedure CI-AKI for patients presenting for coronary angiography procedures. Some of the key CVi® features and methods that can help reduce contrast media usage are adjusting parameters, real-time dose tracking, optimizing the hand controller, using a smaller catheter, and cine diagnosing.
Note: See full resource above for complete citations and references.
This document explores the impact the ACIST CVi® Contrast Delivery System has in reducing angiography complications and cost while delivering value. CVi® can be beneficial in enhancing patient safety, improving workplace safety, and boosting operational efficiency. By reading this document, you will gain insights into the benefits offered by CVi®.
Increasing Patient Safety: Statistics: up to 30% reduction in CI-AKI vs. manual injection. Around a 25% reduction in contrast use without compromising image quality when comparing 4FR to 6FR diagnostic procedures.
Increasing Workplace Safety: Up to 50% reduction in clinician radiation exposure by stepping back. 49.4% of interventional cardiologists have experienced at least one orthopedic injury.8
Increasing Operational Efficiency: 45mL decrease per case when injector used. An average of 5 minutes faster per procedure.
Note: See full resource above for complete citations and references.
FFR-Search is an extensive study investigating the relationship between post-PCI FFR values and clinical outcomes within a real-world patient population. The study employs the ACIST Navvus® Rapid Exchange FFR MicroCatheter, known for its deliverability and crossability. Additionally, this innovative device empowers users with the freedom to select their preferred guidewire, for swift and precise FFR measurements. The study concluded that lower post-PCI values are linked to increased MACE rates at one year. Continue reading to see more results from the study.
“The preliminary data from FFR-Search has the potential to significantly expand this technology’s role in the cath lab in the future, which is why we’re eager to see the important results of the primary endpoint in two years”
FFR-Search Co-PI Dr. Nicolas M. Van Mieghem, MD, PhD, FESC, Director of Interventional Cardiology at Thoraxcenter, Erasmus Medical Center in Rotterdam, Netherlands
Note: See full resource above for complete citations and references.
ACIST informs interventional decisions during cardiovascular disease, structural heart, and peripheral procedures. The ACIST CVi® Contrast Delivery System, RXi® Rapid Exchange FFR System with dPR* (the Non-Hyperemic Index for Coronary Physiology) and the Navvus II® MicroCatheter, and the HDI® HD IVUS System with the Kodama® HD IVUS Catheter give physicians worldwide the ability to visualize, assess and inform patient treatment. CVi® increases safety and overall operational efficiency during the contrast delivery process. RXi® is used to efficiently assess, and confirm coronary artery disease, even in the most complex cases. HDi® is the system of choice for optimized imaging in percutaneous coronary and peripheral interventions.
Physicians worldwide rely on our diagnostic technologies to give them the power to visualize, assess and inform patient treatment. Economic decision-makers appreciate our ability to demonstrate the value of therapeutic intervention.
*not available in all global markets, including the United States
Note: See full resource above for complete citations and references.
ACIST Medical Systems offers diagnostic tools to enhance patient care. Education is a key aspect of our partnership. Clinical evidence highlights the impact of COVID-19 on multiple organs, including the kidneys. Acute kidney injury (AKI) can occur in not just the elderly, but also young and healthy adults with COVID-19. A strong correlation exists between cardiac and kidney injury in COVID-19 patients. AKI is associated with severity and mortality, affecting up to 30% of hospitalized patients. Post-COVID-19 recovery increases the risk of developing chronic kidney disease as well. ACIST CVi™ Contrast Delivery System mitigates the risk of CI-AKI during coronary angiography by reducing contrast dose and preserving renal function. It aligns with SCAI/ACC/AMA guidelines and demonstrates a 22% reduction in contrast delivered compared to the hand manifold. Read to learn more about our solution for optimizing patient care.
Note: See full resource above for complete citations and references.
The ACIST CVi® Contrast Delivery System offers a range of consumable products that aim to simplify setup, effectively manage contrast usage, and ensure precise control and consistency in delivering contrast during angiographic procedures. Among these consumables, you will find the AngioTouch® Hand Controller sets with either ATP or ATX patient kits, both intended for single-patient use. In contrast, the Multi-Use Syringe is suitable for up to 5 patient cases, while the Single-Use Automated Manifold and Pressure Monitoring Kit are designed for single-patient use. To get more specific product information, please continue reading this document.
Note: See full resource above for complete citations and references.
This is a quick guide for learning how to use and implement the ACIST CVi® Contrast Delivery System. There are a variety of components that make up the CVi® Contrast Injector. Some of these include touch screen monitor, saline pump, injector head, mobile cart, among others. Some of the consumables include the patient tubing, hand controller, multi-use syringe product, automated manifold product, and hand controller product. The document breaks into steps how to correctly load contrast, load saline tubing assembly, and purge and flush the tubing. It also expands on the setup of the AngioTouch® Hand Controller and how to perform an injection. Some important activities occur between cases or setups. These include between case activities, following the multi-use syringe procedure, as well as syringe removal and shut down. Lastly CVi® will display any alert messages on the monitor including air column detection, empty contrast, hand controller failure, along with more. Continue reading to learn more about the ACIST CVi® Contrast Delivery System, its parts, set-up, and use, as well as any troubleshooting if need be.
Note: See full resource above for complete citations and references.
Welcome to this comprehensive and concise guide for the HDi® HD IVUS (intravascular ultrasound) System. Familiarizing yourself with the components and their functions is key when utilizing the High-definition IVUS system. Among the essential components are the monitor, console, DVD/USB ports, ports and controls, cart, power supply, Patient Interface Module (PIM), Linear Translation System (LTS), and ACIST Kodama® HD IVUS Catheter. The PIM, equipped with user-friendly buttons, serves to control imaging and recording functions. The LTS enables calibrated pullback, available in both manual and automatic modes. Key consumables for the HDi® system include the Kodama® Catheter and the sterile bag. Further explore this guide to learn essential steps for preparing the HDi® IVUS System for usage. This consists of setting up the Kodama® Catheter, entering patient information, utilizing start and stop live imaging, as well as shutdown procedures and troubleshooting techniques.
Note: See full resource above for complete citations and references.
The ACIST HDi® High-definition IVUS System is designed to enhance visualization, providing valuable insights to guide and enhance coronary and peripheral intervention strategies. This intravascular ultrasound product brings benefits to both patients and medical professionals. With its advanced imaging modules, the HDi® system offers improved clarity and definition, enabling precise pre-procedural planning and accurate post-procedural assessment. The ACIST HDi® features a compact console with a touch screen interface, allowing for efficient analysis and seamless integration into cath lab settings with its small footprint. Notably, the system is now indicated for both coronary and peripheral vasculature procedures, expanding its versatility. The Kodama® HD IVUS Catheter’s optimized deliverability and unique variable flexibility contributes to its ability to capture quality images even in complex procedures. For further information on the ACIST HDi® system, ACIST Kodama®, and to explore imaging results, please continue reading.
Note: See full resource above for complete citations and references.
